Jeffrey Cehelsky

Jeffrey Cehelsky has extensive work experience in the pharmaceutical industry. Jeffrey most recently served as the Vice President of Development Operations at Intellia Therapeutics, Inc. starting in September 2020. Prior to that, they were the Vice President of Clinical Operations at Kaleido Biosciences from November 2018 to September 2020. Jeffrey also held various roles at Alnylam Pharmaceuticals, including Vice President of Clinical Operations from January 2014 to October 2018 and Senior Director of Clinical Operations from September 2005 to January 2014. Additionally, they worked as the Director of Clinical Operations at Millennium Pharmaceuticals from 2003 to 2005 and at Alkermes from 1999 to 2003.

Jeffrey Cehelsky earned a Bachelor of Science degree in Pharmacy from the University of Rhode Island in 1987. Jeffrey then went on to complete a Master of Business Administration degree from the Boston College Carroll School of Management between 1989 and 1993.